Related references
Note: Only part of the references are listed.Janus kinase (JAK) inhibition with baricitinib in refractory juvenile dermatomyositis
Hanna Kim et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Treatment in myositis
Chester V. Oddis et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Consensus-based recommendations for the management of juvenile dermatomyositis
Felicitas Bellutti Enders et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Race, Income, and Disease Outcomes in Juvenile Dermatomyositis
Kathryn Phillippi et al.
JOURNAL OF PEDIATRICS (2017)
Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease
Susan Kim et al.
PEDIATRIC RHEUMATOLOGY (2017)
Assessment, classification and treatment of calcinosis as a complication of juvenile dermatomyositis: a survey of pediatric rheumatologists by the childhood arthritis and rheumatology research alliance (CARRA)
A. B. Orandi et al.
PEDIATRIC RHEUMATOLOGY (2017)
Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America
C. H. Spencer et al.
PEDIATRIC RHEUMATOLOGY (2017)
2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups
Ingrid E. Lundberg et al.
ARTHRITIS & RHEUMATOLOGY (2017)
The juvenile idiopathic inflammatory myopathies: pathogenesis, clinical and autoantibody phenotypes, and outcomes
L. G. Rider et al.
JOURNAL OF INTERNAL MEDICINE (2016)
Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial
Nicolino Ruperto et al.
LANCET (2016)
The Presentation, Assessment, Pathogenesis, and Treatment of Calcinosis in Juvenile Dermatomyositis
Mark F. Hoeltzel et al.
CURRENT RHEUMATOLOGY REPORTS (2014)
Rituximab in the Treatment of Refractory Adult and Juvenile Dermatomyositis and Adult Polymyositis A Randomized, Placebo-Phase Trial
Chester V. Oddis et al.
ARTHRITIS AND RHEUMATISM (2013)
Long-term outcome in patients with juvenile dermatomyositis: a cross-sectional follow-up study
P. Mathiesen et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2012)
Consensus treatments for moderate Juvenile Dermatomyositis: Beyond the first two months. Results of the Second Childhood Arthritis and Rheumatology Research Alliance Consensus Conference
Adam M. Huber et al.
ARTHRITIS CARE & RESEARCH (2012)
Favorable Outcome of Juvenile Dermatomyositis Treated without Systemic Corticosteroids
Deborah M. Levy et al.
JOURNAL OF PEDIATRICS (2010)
Treatment Approaches to Juvenile Dermatomyositis (JDM) Across North America: The Childhood Arthritis and Rheumatology Research Alliance (CARRA) JDM Treatment Survey
Elizabeth Stringer et al.
JOURNAL OF RHEUMATOLOGY (2010)
Mycophenolate Mofetil: A Possible Therapeutic Agent for Children With Juvenile Dermatomyositis
Kelly A. Rouster-Stevens et al.
ARTHRITIS CARE & RESEARCH (2010)
Long-Term Outcome and Prognostic Factors of Juvenile Dermatomyositis: A Multinational, Multicenter Study of 490 Patients
Angelo Ravelli et al.
ARTHRITIS CARE & RESEARCH (2010)
Protocols for the Initial Treatment of Moderately Severe Juvenile Dermatomyositis: Results of a Children's Arthritis and Rheumatology Research Alliance Consensus Conference
Adam M. Huber et al.
ARTHRITIS CARE & RESEARCH (2010)
Complete and Sustained Remission of Juvenile Dermatomyositis Resulting From Aggressive Treatment
Susan Kim et al.
ARTHRITIS AND RHEUMATISM (2009)
The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: A propensity score analysis
Roopa Seshadri et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Rituximab for the treatment of juvenile dermatomyrositis - A report of four pediatric patients
Megan A. Cooper et al.
ARTHRITIS AND RHEUMATISM (2007)
Duration of illness is an important variable for untreated children with juvenile dermatomyositis
LM Pachman et al.
JOURNAL OF PEDIATRICS (2006)
The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids
AV Ramanan et al.
ARTHRITIS AND RHEUMATISM (2005)
US incidence of juvenile dermatomyositis, 1995-1998: Results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry
EP Mendez et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2003)
Aggressive management of Juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis
RE Fisler et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
Share Paper
